Budge James sold $4.4M of HNGE
Budge James (Chief Financial Officer) sold 35,907 shares of Hinge Health, Inc. (HNGE) at an average of $121.62 ($119.52–$123.34, $4.37M total) across 5 trades on 2026-11-10 under a Rule 10b5-1 trading plan.
How this was made
The 30-second read
Why it matters
The disclosed sale provides fresh information on insider sentiment, which may influence short‑term trading decisions.
Market read
A CFO insider sell of $4.4M is a primary disclosure that could modestly affect HNGE's price in the near term.
What to watch
Potential upcoming product launches or earnings could offset the negative signal from the insider sale.
Background
Form 4 filings disclose insider transactions; a CFO sale via a pre‑arranged plan is a standard reporting event.
Ticker impact
CFO Budge James sold 35,907 shares (~$4.4M) via a 10b5-1 plan, reducing his stake to 256,207 shares.
likely downward pressure as the market prices in the CFO's sell-off
A $4.4M sale by the CFO is material but not large enough to trigger a sharp move; it suggests some short‑term weakness.
Market effects
Minimal impact on the broader digital health sector; the sale is company‑specific.
Limited to U.S. investors tracking Hinge Health.
Low; no cross‑border effects.
Counterpoint
The sale could be a routine 10b5‑1 execution unrelated to fundamentals, so the stock may remain stable.
Key entities
- companyHinge Health, Inc.
Digital health platform listed on NASDAQ under ticker HNGE.
- personBudge James
Chief Financial Officer of Hinge Health.
